News&Release

May/11/2020

Introduction of the Nikkei Indexes Consultations
May/11/2020

Index Consultation Regarding the Extraordinary Replacement Rules of the Nikkei Stock Average
May/11/2020

Revision of the policy documents of Nikkei Index Administration
May/01/2020

Notice on Name Change of Nikkei-TOCOM Commodity Index
Apr/16/2020

Deletion from the JPX-Nikkei Index 400
Apr/01/2020

Nikkei Dividend Index reaches its historical high at 457.65 in 2019
Mar/31/2020

Revised Weight Percentage of Nikkei-TOCOM Commodity Index
Mar/30/2020

Estimated Ex-Dividend at 178.26 for the Nikkei 225 Total Return
Mar/27/2020

Initiatives for new corona virus proliferation
Mar/27/2020

Change in Minor Adjustment Date Related to Ex-dividend (JPX-Nikkei 400 and JPX-Nikkei Mid Small)
Mar/19/2020

Annual Review for Nikkei 500
Mar/19/2020

Changes to the Constituent Par Value in Nikkei 500
Mar/17/2020

Calculation of Nikkei Asia300 Philippines Index
Mar/09/2020

Deletion from the JPX-Nikkei Mid and Small Cap Index
Mar/02/2020

Deletion from Nikkei High Dividend Yield 50 constituents
Feb/21/2020

Factsheets at year end 2019 released
Jan/31/2020

Hitachi High-Technologies to remain a component of Nikkei 500 for now
Jan/21/2020

Cancellation of the revisions of the Nikkei Asia300 Index and the Nikkei Asia300 Investable Index dated Dec. 19
Jan/17/2020

Nikkei Stock Index 300 Constituent change
Jan/17/2020

Mitsubishi Tanabe Pharma to Delete from Nikkei 500
Jan/17/2020

Deletion from the JPX-Nikkei Index 400
Jan/13/2020

Today’s index values of Nikkei Asia300 Philippines Index
Dec/23/2019

LINE to remain a component of Nikkei 500 for now
Dec/20/2019

Revisions of the Nikkei Asia300 Index and the Nikkei Asia300 Investable Index dated Dec. 19
Dec/18/2019

Revisions of the Guidebooks for "JPX-Nikkei Index 400” and “JPX-Nikkei Mid and Small Cap Index"
Dec/18/2019

Hitachi Chemical to remain a component of Nikkei 300 and Nikkei 500 for now
Dec/11/2019

Regarding the Stock Split of NTT in Nikkei 225
Dec/11/2019

Change to the Constituent Par Value in Nikkei 500
Nov/18/2019

Mitsubishi Tanabe Pharma to remain a component of Nikkei 300 and Nikkei 500 for now
Nov/13/2019

Change to the Constituent Par Value in Nikkei 500

Guide to make better use of the Nikkei Indexes

The most trusted gauge of the stock markets

Nikkei Inc. has developed and calculated its own indexes from various perspective, looking at changes in society and markets. Nikkei Stock Average, the premier and flagship index of Japanese stocks, and other Nikkei Indexes are widely used globally as representative indicators of the Japanese equity market, and financial products linked to the Nikkei Indexes are traded around the world.

License Agreement

Nikkei retains all intellectual property rights to the Nikkei Stock Average and other Nikkei Indexes. In addition to displaying the data on our website and mobile apps, Nikkei guides information on approval procedures for different usage patterns, including display and non-display usage of the indexes, and creation of financial instruments on the indexes.

More details

Provision of index data

This section provides information on the procedures for using basic data in business use such as index constituents stock prices, dividends and weights, which are indispensable for calculating the Nikkei Stock Average, for business use.

More details

FAQ

Here you will find answers to your questions about the Nikkei Stock Average and other Nikkei Indexes, as well as licensing agreements and use of this site.

View all FAQ

Contact us

Please contact us here for any questions about the Nikkei Indexes, your interest in using the Nikkei Indexes for business purposes and/or any comments about this site.

Contact us from here